Meyka Pro banner
Fifth Third Bancorp

Stay Updated with the Latest Fifth Third Bancorp FITB-PA News in Real Time

Find FITB-PA news now at Meyka AI. Stay informed with the latest Fifth Third Bancorp stocks updates, including price news, market analysis, and expert insights.

FITB-PANYSE
Financial ServicesBanks - Regional
$21.69
$0.31(1.41%)
U.S. Market opens in 11h 48m
Bayern’s Ibrahimovic Open to Exit as Werder, Union Circle August 28
📅 in about 5 hours

Bayern’s Ibrahimovic Open to Exit as Werder, Union Circle August 28

Bayern Munich open to loaning Arijon Ibrahimovic before September 1 deadline. Werder Bremen and Union Berlin interested; Atalanta seeking permanent transfer. 20-year-old unhappy with club’s public statements.

Read more 12
Sonal Dinusha Scores Twin Centuries vs India, Joins Elite Test Club on August 27
📅 2 hours ago

Sonal Dinusha Scores Twin Centuries vs India, Joins Elite Test Club on August 27

Sonal Dinusha scores 103 and 133* in Colombo Test, becoming third batter ever to score centuries in both innings after follow-on. Sri Lanka draws 2nd Test vs India.

Read more 12
Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27
📅 4 hours ago

Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27

Ismail Sabri Yaakob, Malaysia’s shortest-serving PM, charged with concealing US$40M in undeclared assets including foreign currencies and gold bars. Faces up to 5 years prison if convicted.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 8 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12
Nvidia Stock Drops 1.6% Despite $96.2B Revenue Beat on August 27
📅 10 hours ago

Nvidia Stock Drops 1.6% Despite $96.2B Revenue Beat on August 27

Nvidia posts record $96.2B Q2 revenue and forecasts 70% growth for fiscal 2028, but stock slides 1.6% as investors fret over slowing expansion and supply limits.

Read more 12
Halfords (HFD) Shares Jump 12% to 4-Year High After Raising FY27 Profit Forecast
📅 10 hours ago

Halfords (HFD) Shares Jump 12% to 4-Year High After Raising FY27 Profit Forecast

Halfords shares surged as much as 13.9% to 274.50p on August 27, 2026, marking a fresh 52-week high. Shares later settled near 268.00p, up 11.2% from Wednesday’s close of 241.00p. The UK’s largest motoring and cycling retailer raised its FY27 underlying profit guidance to £55 million-£65 million. That range sits well above the prior consensus…

Read more 12
Baby Boomers Collect 265% of Social Security Contributions as Millennials Fund Gap
📅 10 hours ago

Baby Boomers Collect 265% of Social Security Contributions as Millennials Fund Gap

Baby boomers retiring in 2027 will collect $730,000 in Social Security benefits on less than $200,000 in combined taxes paid, according to a nonpartisan budget analysis. Millennials are funding the shortfall.

Read more 12
Canada Hits US With C$27.6B Tariff Counterpunch on September 8
📅 15 hours ago

Canada Hits US With C$27.6B Tariff Counterpunch on September 8

Canada imposes C$27.6B in retaliatory tariffs on U.S. goods starting September 8, matching U.S. rates of 15-50% after trade talks fail. Steel, aluminum, and paper products face 50% duties.

Read more 12
Federal Judge Blocks Texas Drag Show Ban for Second Time on August 26
📅 19 hours ago

Federal Judge Blocks Texas Drag Show Ban for Second Time on August 26

Federal Judge David Hittner struck down Texas Senate Bill 12 on August 26, ruling the drag show ban unconstitutional and a First Amendment violation. The law would have fined businesses $10,000 and jailed performers for a year.

Read more 12

FITB-PA News FAQ